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. The procedure requires that both donor and recipient match human leukocyte antigen (HLA) type. Human leukocyte antigens are inherited "markers" on the white cell which help the body to distinguish its own cell and tissue from that of others. The chance of a successful transplant is determined by how well the markers match between donor and recipient.
About 25% to 30% of persons diagnosed with a fatal blood disease will be able to find a donor within their family (Kerman, 1993) . The remaining 70% to 75% must depend on volunteers for a match. The chances of finding an unrelated donor range from 1 in 100 to 1 in 1,000,000 (BMDP, 1992) . Thus, a large number of volunteers are needed to increase the chance of matching unrelated donors.
THE NATIONAL MARROW DONOR PROGRAM
Between 1968 and the mid-1980s, local bone marrow donor centers throughout the United States operated independently. Although they interacted with other centers, locating donors was time consuming and resulted in unacceptable waiting time for the recipients. The NMDP was established in 1986 to coordinate finding suitable unrelated donors.
The NMDP is a group of donor centers, transplant centers, and blood collection centers that provide a coordinated and comprehensive effort to locate donors and match them to recipients. In 1990, the NMDP became a non-profit Congressionally authorized corporation. The NMDP, located in Minneapolis, is funded in part by the National Heart, Lung, and Blood Institute and by individual contributors. The NMDP maintains a national computerized registry of potential bone marrow donors.
. Potential bone marrow donors are typed by HLA tissue and registered in one of two ways. Phase I testing provides an initial screening by typing HLA-A and B. Phase II tests for HLA-D and R, which provide more definitive information on matching. The registry shares information as well as donor marrow through contacts with registries in the United States and other countries (BMDP, 1992) .
The success of the NMDP requires that it identifies a large pool of potential donors, recruited through blood centers, the media, and community programs. It also looks to corporations to identify volunteers to become potential donors. As of 1995, the NMDP has 1,500,000 volunteer donors worldwide listed in their registry. However, because it is difficult to match unrelated donors, many more donors are needed to meet the increasing needs of potential bone marrow transplant recipients (S. Gurske, personal communication, May 25, 1995) .
CORPORATE BONE MARROW SCREENING PROGRAM

Company Support and Goal
The philosophy of the chemical specialty corporation is that businesses should give something back to the community in which they operate. The company occupational medicine physician was instrumental in convincing the CEO to fund the program. Corporate funds provided facilities for the screening and refreshments for the donors and bore the cost associated with the HLA typing.
Although Phase II testing costs approximately double that of Phase I, the corporation opted to initiate Phase II testing, which substantially decreases the waiting time for matching donors. The company's goal was to support the BMDP by recruiting employees to test and become registered in the national computerized database.
Planning
The occupational health nurse met with representatives from the Bone Marrow Recruitment Department of the regional blood center several times to plan "The Living Gift of Life" program. Beatty (1989) reported that during a blood drive 6.2% of age eligible blood donors were recruited into the NMDP with minimal effort. Consequently, the planning committee decided to incorporate the bone marrow screening with the annual blood drive to facilitate drawing blood and to use resources efficiently.
The major focus of the planning was to make sure that each participant would be well informed of the process. In addition, the planning committee would need to make sure employees understood that registration in the BMDP involves a potential commitment to donate marrow.
To determine how many employees were interested in being tested, a letter was sent to all employees. They were provided with an overview of the bone marrow JULY 1995, VOL. 43, NO. 7 donor program and what registration entails. The interest generated by the letter was greater than expected. To accommodate as many employees as possible, two screenings were planned. Six weeks before the screening date, the occupational health nurse selected blood drive captains from each department to be key resource persons. The blood drive captains were invited to a meeting, 4 weeks before the first screening, to provide in depth information on the bone marrow screening and donor process. Captains were informed that their roles were to be a source of information about the bone marrow screening and donor process, to distribute printed materials to interested employees, and to direct questions back to the occupational health nurse. Each captain was given a folder with packets of literature supplied by the BMDP for employees in their departments.
During the informational meeting with captains, a panel from the BMDP explained the entire process. Captains were informed that employees who met the screening criteria (see Table) could elect to have HLA typing and donate blood or HLA typing only. To have blood drawn for HLA typing requires written consent.
The screening procedure involves drawing two tubes of blood (approximately 40 mL) and having the screenee's name and HLA type registered with the BMDP. In the event of an initial match, additional blood tests and counseling are required. If the additional blood tests indicate a high probability of a successful transplant , a detailed session is arranged with the screenee to provide further educational material, counseling, further tissue typing, and a complete physical examination. During this session, the potential donor is shown a videotape on the donor preparation process, and questions are encouraged and answered by BMDP personnel. Following this additional session, the screenee can decide whether or not to donate bone marrow.
Three weeks before the screening date, employees who had indicated their interest in the BMDP were mailed materials. These materials consisted of two brochures: Bone Marrow Transplantation Program and The Chance of a Lifetime, and a handout entitled How Do I Become a Marrow Donor? The BMDP provided two videotapes, one for participants to view at the health center and another which could be viewed off site.
Tho weeks before the screening date, an informational booth was set up in both cafeterias for 2 consecutive days each. The BMDP personnel showed a videotape, handed out literature, and answered questions. Employees were encouraged to call the occupational health nurse with any further questions.
1.
2.
3.
Although bone marrow transplants increase the survival rate of persons with fatal blood diseases, identifying donors requires a large pool of volunteers.
Community involved corporations can support the Bone Marrow Donor Program by facilitating bone marrow screening in the workplace.
Collaboration is needed to effectively implement a bone marrow screening program at the worksite.
Implementation
The first screening was held at the manufacturing site and the second was held several months later at the corporate site. A general health history was obtained by NMDP personnel to determine if the potential screenee met all screening criteria. For those who met the criteria, written consent was obtained prior to venipuncture. The occupational health nurse registered each screenee and directed each of them to one of two stations-blood donation and HLA testing or HLA testing only. The occupational health nurse also answered any questions about the blood drawing procedure. Representatives from the blood center performed venipuncture procedures for both the bone marrow testing and the blood drive.
Evaluation
A total of 137 out of approximately 2,500 employees (5.5%) participated in the program. Within 12 months of the screening program, one employee was identified as a potential match, and upon further tissue typing, decided to donate his bone marrow. Finding a suitable donor was a significant event not only for the marrow recipient and the company, but also for the regional blood bank. This employee was the 200th unrelated bone marrow donor for the regional blood bank and only 1 of approximately 1,700 people worldwide to donate bone marrow to a non-relative.
The BMDP hosted a ceremony to honor the donor who received a certificate of appreciation . The company received an award from the BMDP, not only for being one of the first corporations to support a bone marrow screening, but also for being one of the first to fund Phase II testing. The company funded 122 tests for HLA-D and 378 R ($ 155 each) and four for HLA-A and B ($75 each) for a total cost of $19,210. Because of the critical need for minority donors, HLA-A and B typing was done for 11 minorities at no cost to the company. The cost of the bone marrow transplant was paid by the recipient. The donor took 2 days of sick leave for the procedure and spent the weekend at home to fully recover. Alternatively, the donor could have used vacation or compensatory time.
CONCLUSION
The corporation and its employees derived great satisfaction in providing this life saving community service. Through its support and funding it was able to help increase the number of volunteers registered in the BMDP. In addition, it was able to extend limited federal funds and personal contributions that are available for bone marrow testing. Occupational health nurses can be active participants in the initiation, planning, and coordination of a bone marrow screening program.
